Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bardou

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Gastrointestinal Endoscopy|October 26, 2010
Prokinetics in acute upper GI bleeding: a meta-analysisAlan N Barkun, Marc Bardou, Myriam Martel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOSPascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatinZo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
Cancers|March 25, 2022
Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE TrialDolorès Pourette, Amber Cripps, Margaux Guerrien, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the ratZo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Clinical and Translational Science|February 16, 2026
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19Inès Ben Ghezala, Nathan Peiffer-Smadja, Caroline Solas, et al.
British Journal of Pharmacology|March 3, 2004
Nociceptin inhibits airway microvascular leakage induced by HCl intra-oesophageal instillationCéline Rouget, Yong Yao Cui, Bruno D'Agostino, et al.
American Journal of Obstetrics and Gynecology|July 26, 2011
Effects of leptin on lipopolysaccharide-induced myometrial apoptosis in an in vitro human model of chorioamnionitisMaeva Wendremaire, Marc Bardou, Caroline Peyronel, et al.
Therapie|July 29, 2023
Experience and expectations of pharmacogenetic tests in FranceSimon Verdez, Marc Bardou, Yannis Duffourd, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2019
Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohortMaxime Luu, Eric Benzenine, Alan Barkun, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Gastrointestinal Endoscopy|October 26, 2010
Prokinetics in acute upper GI bleeding: a meta-analysisAlan N Barkun, Marc Bardou, Myriam Martel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOSPascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatinZo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
Cancers|March 25, 2022
Assessing the Acceptability of Home-Based HPV Self-Sampling: A Qualitative Study on Cervical Cancer Screening Conducted in Reunion Island Prior to the RESISTE TrialDolorès Pourette, Amber Cripps, Margaux Guerrien, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the ratZo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Clinical and Translational Science|February 16, 2026
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19Inès Ben Ghezala, Nathan Peiffer-Smadja, Caroline Solas, et al.
British Journal of Pharmacology|March 3, 2004
Nociceptin inhibits airway microvascular leakage induced by HCl intra-oesophageal instillationCéline Rouget, Yong Yao Cui, Bruno D'Agostino, et al.
American Journal of Obstetrics and Gynecology|July 26, 2011
Effects of leptin on lipopolysaccharide-induced myometrial apoptosis in an in vitro human model of chorioamnionitisMaeva Wendremaire, Marc Bardou, Caroline Peyronel, et al.
Therapie|July 29, 2023
Experience and expectations of pharmacogenetic tests in FranceSimon Verdez, Marc Bardou, Yannis Duffourd, et al.
Alimentary Pharmacology & Therapeutics|October 17, 2019
Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohortMaxime Luu, Eric Benzenine, Alan Barkun, et al.
Pageof 15